Assessing risk and mortality of venous thromboembolism in pancreatic cancer patients

Anticancer Research

Volumn 30, Issue 10, 2010, Pages 4261-4264

  Shaib, Walid ^a   Deng, Yanhong ^a   Zilterman, Daniel ^b   Lundberg, Bruce ^a   Saif, Muhammad Wasif ^c  

^a HOSPITAL OF SAINT RAPHAEL   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Assessment of risk and mortality; Pancreatic cancer; Venous thromboembolism

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER OF UNKNOWN PRIMARY SITE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL TIME; VENOUS THROMBOEMBOLISM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; VENOUS THROMBOEMBOLISM;

EID: 78650249815     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. Cancer J Clin 59(4): 225-249, 2009.
2. Riess H, Pelzer U, Hilbig A, Stieler J, Opitz B, Scholten T, Kauschat-Brüning D, Bramlage P, Dörken B and Oettle H: Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy. BMC Cancer 8: 361, 2008.
3. Sproul EE: Carcinoma and venous thrombosis: the frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. Am J Cancer 34: 566-573, 1938.
4. Sack GH Jr., Levin J and Bell WR: Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) 56(1): 1-37, 1977. (Pubitemid 8029158)
5. Mikal S and Campbell AJ: Carcinoma of the pancreas; diagnostic and operative criteria based on 100 consecutive autopsies. Surgery 28(6): 963-969, 1950.
6. Thodiyil PA and Kakkar AK: Variation in relative risk of venous thromboembolism in different cancers. Thromb Haemost 87(6): 1076-1077, 2002.
7. Blom JW, Osanto S and Rosendaal FR: High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients. Eur J Cancer 42(3): 410-414, 2006. (Pubitemid 43132898)
8. Blom JW, Osanto S and Rosendaal FR: The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost 2(10): 1760-1765, 2004. (Pubitemid 40192717)
9. Khorana AA and Connolly GC: Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol Vol 27, No 29 (October 10): pp. 4839-4847, 2009.
10. Cubilla AL and Fitzgerald PJ: Pancreas cancer (non-endocrine): a review-part I. Clin Bull 8(3):91-99, 1978.
11. Pinzon R, Drewinko B, Trujillo JM, Guinee V and Giacco G: Pancreatic carcinoma and Trousseau's syndrome: experience at a large cancer center. J Clin Oncol 4(4): 509-514, 1986. (Pubitemid 16117940)
12. Mao C, Domenico DR, Kim K, Hanson DJ and Howard JM: Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies Arch Surg 130(2): 125-134, 1995.
13. Blom JW, Osanto S and Rosendaal FR: High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients. Eur J Cancer 42(3): 410-414, 2006. (Pubitemid 43132898)
14. Mandalà M, Reni M, Cascinu S, Barni S, Floriani I, Cereda S, Berardi R, Moscon S, Torri V and Labianca R: Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients. Ann Oncol 18(10): 1660-1665, 2007.
15. Mitry E, Taleb-Fayad R, Deschamps A, Mansencal N, Lepère C, Declety G, Lièvre A, Vaillant JN, Lesur G, Cramer E, Dubourg O and Rougier P: Risk of venous thrombosis in patients with pancreatic adenocarcinoma. Gastroenterol Clin Biol 31(12): 1139-1142, 2007.
16. Oh SY, Kim JH, Lee KW, Bang SM, Hwang JH, Oh D and Lee JS: Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity. Thromb Res 122(4): 485-490, 2008.
17. Epstein AS, Crosbie C, Gardos S, Soff GA, Shah MA, Kelsen DP, O'Reilly EM: A single-institution (MSKCC) analysis of incidence and clinical outcomes in patients with thromboembolic events and exocrine pancreas cancer. J Clin Oncol 28: 7s, 2010.
18. Hull R, Pineo GF, Mah A, Burke N, Dear R, Wong T, Cook R, Solymoss S and Poon M: A randomised trial evaluating long-term low-molecular weight heparin therapy for three months vs. intravenous heparin followed by warfarin sodium in patients with current cancer. Am J Med 119(12): 1062-1072, 2006.
19. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ and Gent M: Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349(2): 146-153, 2003.
20. Meyer G, Marjanovic Z, Valcke J, Lorcerie B, Gruel Y, Solal-Celigny P, Le Maignan C, Extra JM, Cottu P and Farge D: Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch Intern Med 162(15): 1729-1735, 2002.
21. Palareti G, Legnani C, Lee A, Manotti C, Hirsh J, D'Angelo A, Pengo V, Moia M and Coccheri S: A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy. Thromb Haemost 84(5): 805-810, 2000.
22. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH and Raskob GE: Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl): 401S-428S, 2004. (Pubitemid 39297960)
23. Icli F, Akbulut H, Utkan G, Yalcin B, Dincol D, Isikdogan A, Demirkazik A, Onur H, Cay F and Buyukcelik A: Low-molecular-weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer. J Surg Oncol 95(6): 507-512, 2007.
24. El-Rayes BF, Zalupski MM, Shields AF, Vaishampayan U, Heilbrun LK, Jain V, Adsay V, Day J and Philip PA: Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer. J Clin Oncol 21(15): 2920-2925, 2003.